Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer

NCT05673343 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05673343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 4, 2023
Completion date
March 1, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the prognostic value of pre-treatment nlr in patients with locally advenced rectal cancer and post-treatment